Animal pharmacokinetics and interspecies scaling from animals to man of lamifiban, a new platelet aggregation inhibitor

Journal of Pharmacy and Pharmacology

Volumn 48, Issue 6, 1996, Pages 573-577

  Lave, Thierry ^a   Saner, Alphonse ^a   Coassolo, Philippe ^a   Brandt, R ^a   Schmitt Hoffmann, Anne H ^a   Chou, Ruby C ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBOCYTIC AGENT; FIBRINOGEN RECEPTOR; LAMIFIBAN;

ALLOMETRY; ANIMAL EXPERIMENT; ARTICLE; CLINICAL TRIAL; DOG; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG INFORMATION; HEART MUSCLE ISCHEMIA; HUMAN; HUMAN EXPERIMENT; INTRAVENOUS DRUG ADMINISTRATION; MALE; METHODOLOGY; MONKEY; NONHUMAN; NORMAL HUMAN; PROSPECTIVE STUDY; RAT; SPECIES DIFFERENCE; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0030036409     PISSN: 00223573     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.2042-7158.1996.tb05976.x     Document Type: Article

References (14)

1. Boxenbaum, H. (1984) Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm. Drug Metab. Rev. 15: 1071-121
2. Boxenbaum, H., Ronfeld, R. (1983) Interspecies pharmacokinetic scaling and the Dedrick plots. Am. J. Physiol. 245: R768-775
3. Coller, B. S. (1990) Platelets and thrombolytic therapy. N Engl. J. Med. 322: 33-42
4. Davies, B., Morris, T. (1993) Physiological parameters in laboratory animals and humans. Pharm. Res. 10: 1093-1095
5. Dedrick, R. L., Bischoff, K. B., Zaharko, D. S. (1970) Interspecies correlation of plasma concentration, history of methotrexate (NSC-740). Cancer Chemother. Rep. 54: 95-101
6. Efthymiopoulos, C., Battaglia, R., Strolin-Benedetti, M. (1991) Animal pharmacokinetics and Interspecies scaling of FCE 22101, a penem antibiotic. J. Antimicrob. Chemother. 27: 517-526
7. Fleck, C., Bräunlich, H. (1990) Factors determining the relationship between renal and hepatic excretion of xenobiotics. Arzneim. Forsch. - Drug Res. 40: 942-946
8. Lave, T., Schmitt-Hoffmann, A. H., Coassolo, P., Ubeaud, G., Vallès, B., Ba, B., Brandt, R., Chou, R. C. (1995) A new extrapolation method from animal to man; application to a metabolized compound, mofarotene. Life Sci. 56: 473-478
9. Mordenti, J. (1986) Man versus beast: pharmacokinetic scaling in mammals. J. Pharm. Sci. 75: 1028-1040
10. Mordenti, J., Chen, S. A., Moore, J. A., Ferraiolo, B. L., Green, J. D. (1991) Interspecies scaling of clearance and volume of distribution data for five therapeutic proteins. Pharm. Res. 8: 1351-1359
11. Plow, E. F., Giusberg, M. H. (1988) Cellular adhesion: GP IIb-IIIa as a prototypic adhesion receptor. Prog. Hem. Thromb. 9: 117-156
12. Sawada, Y., Hanano, M., Sugiyama, Y., Iga, T. (1984) Prediction of the disposition of beta-lactam antibiotics in humans from pharmacokinetic parameters in animals. J. Pharmacokinet. Biopharm. 12: 241-61
13. Swabb, E. A., Bonner, D. P. (1983) Prediction of aztreonam pharmacokinetics in humans based on data from animals. J. Pharmacokinet. Biopharm. 11: 215-23
14. Washington, C., Washington, N., Wilson, C. (1987) In: Pharmacokinetic Modelling Using Stella on the Apple Macintosh. Ellis Horwood, New York